On the basis of an elaborate conformational analysis of m1- and m2-sel
ective antagonists a respective pharmacophore was deduced. This then w
as introduced into models of the two muscarinic receptor subtypes. The
se models were constructued starting from bacteriorhodopsin as a templ
ate in accordance with alignment data and mutation experiments. The va
lidity of the interaction geometries between ligands and receptor subt
ypes is supported by a significant correlation between calculated inte
raction energies and experimentally determined affinity data.